Will This Billion-Dollar Acquisition Be a Smart Move for Merck?

Will This Billion-Dollar Acquisition Be a Smart Move for Merck?

Source: 
Motley Fool
snippet: 

  • The pharma giant just purchased Imago BioSciences for nearly $1.4 billion.
  • This move bolsters its oncology portfolio and includes a drug with blockbuster potential.
  • Merck’s stock remains an all-around bargain for just about every investing strategy.